Paper41525337
Oligosaccharyltransferase (OST) complex inhibition effectively treats rodent and human prions.
Beauchemin KS and 8 others. PLoS Pathog, 2026. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Oligosaccharyltransferase (OST) complex inhibition effectively treats rodent and human prions. Papers, record 41525337. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41525337
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Oligosaccharyltransferase (OST) complex inhibition effectively treats rodent and human prions.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hexosyltransferases | Major topic |
| Membrane Proteins | Major topic |
| Prion Diseases | Major topic |
| Prions | Major topic |
| Humans | |
| Animals | |
| Mice | |
| Glycosylation | |
| Enzyme Inhibitors |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P20 GM113132 | NIGMS NIH HHS | United States | P20GM113132 | PubMed | NIH RePORTER |
| T32 AI007519 | NIAID NIH HHS | United States | T32AI007519 | PubMed | NIH RePORTER |
| R37 NS125431 | NINDS NIH HHS | United States | R37NS125431 | PubMed | NIH RePORTER |
| R01 NS118796 | NINDS NIH HHS | United States | R01NS118796 | PubMed | NIH RePORTER |
| R01 NS117276 | NINDS NIH HHS | United States | R01NS117276 | PubMed | NIH RePORTER |
References97
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8003954 | Crystal structure of cholera toxin B-pentamer bound to receptor GM1 pentasaccharide. | Protein Sci | 1994 | https://conductscience.org/library/papers/8003954 | PubMed |
| 2 | 22743772 | Fiji: an open-source platform for biological-image analysis. | Nat Methods | 2012 | https://conductscience.org/library/papers/22743772 | PubMed |
| 3 | 34904943 | Alternating anti-prion regimens reduce combination drug resistance but do not further extend survival in scrapie-infected mice. | J Gen Virol | 2021 | https://conductscience.org/library/papers/34904943 | PubMed |
| 4 | 17115708 | The stoichiometry of host PrPC glycoforms modulates the efficiency of PrPSc formation in vitro. | Biochemistry | 2006 | https://conductscience.org/library/papers/17115708 | PubMed |
| 5 | 2574992 | Diversity of oligosaccharide structures linked to asparagines of the scrapie prion protein. | Biochemistry | 1989 | https://conductscience.org/library/papers/2574992 | PubMed |
| 6 | 29924488 | Transcription Factor-Mediated Differentiation of Human iPSCs into Neurons. | Curr Protoc Cell Biol | 2018 | https://conductscience.org/library/papers/29924488 | PubMed |
| 7 | 23408888 | Acquisition of drug resistance and dependence by prions. | PLoS Pathog | 2013 | https://conductscience.org/library/papers/23408888 | PubMed |
| 8 | 23583305 | N-linked protein glycosylation in the ER. | Biochim Biophys Acta | 2013 | https://conductscience.org/library/papers/23583305 | PubMed |
| 9 | 23604588 | Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease. | Acta Neuropathol | 2013 | https://conductscience.org/library/papers/23604588 | PubMed |
| 10 | 19278902 | Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trial. | Lancet Neurol | 2009 | https://conductscience.org/library/papers/19278902 | PubMed |
| 11 | 33444414 | Short and sweet: How glycans impact prion conversion, cofactor interactions, and cross-species transmission. | PLoS Pathog | 2021 | https://conductscience.org/library/papers/33444414 | PubMed |
| 12 | 9122195 | COOH-terminal sequence of the cellular prion protein directs subcellular trafficking and controls conversion into the scrapie isoform. | Proc Natl Acad Sci U S A | 1997 | https://conductscience.org/library/papers/9122195 | PubMed |
| 13 | 23965382 | Biaryl amides and hydrazones as therapeutics for prion disease in transgenic mice. | J Pharmacol Exp Ther | 2013 | https://conductscience.org/library/papers/23965382 | PubMed |
| 14 | 37156804 | Glycosylation and behavioral symptoms in neurological disorders. | Transl Psychiatry | 2023 | https://conductscience.org/library/papers/37156804 | PubMed |
| 15 | 8552188 | Normal host prion protein necessary for scrapie-induced neurotoxicity. | Nature | 1996 | https://conductscience.org/library/papers/8552188 | PubMed |
| 16 | 4206342 | Comparison of the tissue receptors for Vibrio cholerae and Escherichia coli enterotoxins by means of gangliosides and natural cholera toxoid. | Infect Immun | 1973 | https://conductscience.org/library/papers/4206342 | PubMed |
| 17 | 10409615 | Sphingolipid depletion increases formation of the scrapie prion protein in neuroblastoma cells infected with prions. | J Biol Chem | 1999 | https://conductscience.org/library/papers/10409615 | PubMed |
| 18 | 21152012 | Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays. | PLoS Pathog | 2010 | https://conductscience.org/library/papers/21152012 | PubMed |
| 19 | 11470893 | Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody. | Proc Natl Acad Sci U S A | 2001 | https://conductscience.org/library/papers/11470893 | PubMed |
| 20 | 32776089 | Prion protein lowering is a disease-modifying therapy across prion disease stages, strains and endpoints. | Nucleic Acids Res | 2020 | https://conductscience.org/library/papers/32776089 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42842018 | From a prion seed to a tree of discoveries: Byron Caughey's RT-QuIC legacy in protein misfolding research. | Acta Neuropathol | 2026 | https://conductscience.org/library/papers/42842018 | PubMed |
| 42762360 | Life at the interface: Byron Caughey's search for prion disease inhibitors through chemistry, structure, and cell physiology. | Acta Neuropathol | 2026 | https://conductscience.org/library/papers/42762360 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| DDOST | 1650 | PubTator's text mining | https://conductscience.org/library/genes/1650 | NCBI Gene |
| PRNP | 5621 | PubTator's text mining | https://conductscience.org/library/genes/5621 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41525337
GET https://conductscience.org/api/papers/v1/41525337/references?page=2